Assessment of efficiency and safety of application of the reproduced drug of Mertenil® according to MSCT-coronary angiography
In article possibility of an assessment of efficiency of therapy by the reproduced drug Mertenil of production of JSC Gideon Richter (Hungary) appointed for the purpose of primary prevention of the cardiovascular diseases. Increase of level of lipoproteid of the low density is one of the most powerf...
Main Authors: | Malov A.A., Feiskhanova L.I. |
---|---|
Format: | Article |
Language: | Russian |
Published: |
IP Morozov P.V.
2016-06-01
|
Series: | Системные гипертензии |
Subjects: | |
Online Access: | http://syst-hypertension.ru/en/archive/2016/vol-13-2-2016/assessment-of-efficiency-and-safety-of-application-of-the-reproduced-drug-of-mertenil-according-to-m_1905/ |
Similar Items
-
Assessment of efficiency and safety of application of the reproduced drug of Mertenil® according to MSCT-coronary angiography
by: A A Malov, et al.
Published: (2016-06-01) -
Efficacy and safety of Mertenil (rosuvastatin) 40 mg in patients with familial hypercholesterolemia
by: M Yu Zubareva, et al.
Published: (2014-06-01) -
The evaluation of the coronary arteries calcification degree by the method of cardiovascular MSCT in patients with vitamin D and homocysteine metabolism disturbance
by: O. S. Nykonenko, et al.
Published: (2020-06-01) -
Association of atrial fibrillation with coronary bed lesions (according to the coronary angiography register)
by: E. I. Yaroslavskaya, et al.
Published: (2019-08-01) -
Positive remodeling index by MSCT coronary angiography: A prognostic factor for early detection of plaque rupture and vulnerability
by: Emad H. Abdeldayem, et al.
Published: (2015-03-01)